https://www.openbell.ai/ 2026-10-01T12:15:06.409Z hourly 1.0 https://www.openbell.ai/support 2026-10-01T12:15:06.409Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-01T12:15:06.409Z monthly 0.5 https://www.openbell.ai/terms 2026-10-01T12:15:06.409Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-01T12:15:06.409Z hourly 0.8 https://www.openbell.ai/news/UTHR:1790856884208 2026-10-01T12:14:44.208Z daily 0.9 https://cdn.brandfetch.io/UTHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia United Therapeutics Corp (NASDAQ: UTHR) shares rose 1.44% to $549.69 in premarket trading following a federal court victory in its patent litigation against Liquidia Corp. The U.S. District Court for the District of Delaware ruled that Liquidia infringed on United Therapeutics' patent related to inhaled treprostinil for treating pulmonary hypertension. As a result, United Therapeutics plans to seek a court order to withdraw FDA approval for Liquidia's Yutrepia and pursue monetary damages. Additionally, BTIG analyst Julian Harrison upgraded United Therapeutics from Neutral to Buy with a price target of $728. https://www.openbell.ai/news/ACN:1790856803321 2026-10-01T12:13:23.321Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud AI Threat? Accenture Posts Record Big-Ticket Client Bookings Accenture plc (NYSE: ACN) reported fiscal Q4 2026 earnings of $3.29 per share, exceeding the analyst estimate of $3.18, with revenue rising 6% year-over-year to $18.70 billion, surpassing the $18.03 billion consensus. The company achieved new bookings of $22.2 billion, a 4% increase, and generated $2.85 billion in free cash flow. For fiscal 2027, Accenture projects adjusted earnings of $14.39 to $14.81 per share and revenue between $76.43 billion and $78.65 billion, both above analyst expectations. Following the report, Accenture shares surged by 19.70% in premarket trading. https://www.openbell.ai/news/GEVO:1790856751031 2026-10-01T12:12:31.031Z daily 0.9 https://cdn.brandfetch.io/GEVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Gevo Announces Sells All 2026 Section 45Z Tax Credits, Totaling $70M Worth Of Credits openbell Financial News https://www.openbell.ai/news/SXTP:1790856728681 2026-10-01T12:12:08.681Z daily 0.9 https://cdn.brandfetch.io/SXTP/w/400/h/400?c=1idopYfmtR7ZKg8QMud 60 Degrees Pharmaceuticals To Present Data On Interim Analysis From Its Clinical Trial Of Tafenoquine On Oct. 6 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) will present the results of an interim analysis from its clinical trial evaluating tafenoquine in patients with severe babesiosis on October 6, 2026. The company focuses on developing new medicines for vector-borne diseases. https://www.openbell.ai/news/SGP:1790856663539 2026-10-01T12:11:03.539Z daily 0.9 https://cdn.brandfetch.io/SGP/w/400/h/400?c=1idopYfmtR7ZKg8QMud SpyGlass Pharma Acquires Advanced Vision Science For ~$13M In Cash SpyGlass Pharma, Inc. has acquired Advanced Vision Science, Inc. (AVS) for approximately $13 million in cash. This acquisition secures scalable manufacturing capacity for SpyGlass's Phase 3 BIM-IOL System and allows for the addition of premium lens options. AVS, previously a subsidiary of Santen Pharmaceutical Co., will continue to supply various IOLs to Santen for commercialization in Japan and license its lens material technology to Bausch + Lomb and other companies. https://www.openbell.ai/news/CADL:1790856663410 2026-10-01T12:11:03.410Z daily 0.9 https://cdn.brandfetch.io/CADL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Candel Publishes Final Phase Of 2a Clinical Trial Results Of of Aglatimagene Besadenovec Plus Valacyclovir In Patients With Stage III/IV NSCLC Showing Inadequate Response To ICI. Candel has published the final phase of its Phase 2a clinical trial results for Aglatimagene Besadenovec combined with Valacyclovir in patients with Stage III/IV non-small cell lung cancer (NSCLC) who showed inadequate response to immune checkpoint inhibitors (ICI). The peer-reviewed study, published in the Journal for ImmunoTherapy of Cancer, reports a median overall survival of 24.5 months for these patients. https://www.openbell.ai/news/KMI:1790856641953 2026-10-01T12:10:41.953Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Jim-Cramer-Says-He-Envies-AMD--Dell-Shar.jpg?width=250&height=187 Jim Cramer Recommends Buying This Energy Stock: It Is ‘Too Cheap’ Jim Cramer recommended buying Kinder Morgan (NYSE: KMI), stating the stock is undervalued at 19 times earnings. RBC Capital analyst Elvira Scotto raised the price target for Kinder Morgan from $35 to $36. On the market front, Kinder Morgan shares fell 1% to settle at $30.15, while MPLX and POET Technologies also experienced declines of 1.3% and 2.5%, respectively. https://www.openbell.ai/news/AEHL:1790856571904 2026-10-01T12:09:31.904Z daily 0.9 https://cdn.brandfetch.io/AEHL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Antelope Enterprise Files Prospectus For Sale Of Up To $100M Shares Through Or To D. Boral Capital Antelope Enterprise has filed a prospectus for the sale of up to $100 million in Class A ordinary shares through D. Boral Capital LLC, which will act as the sales agent or principal. This initiative is part of an At Market Issuance Sales Agreement established on October 1, 2026. The offering will occur over time as specified in the prospectus. https://www.openbell.ai/news/NXTT:1790856554588 2026-10-01T12:09:14.588Z daily 0.9 https://cdn.brandfetch.io/NXTT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Next Technology Announces $35M R&D Initiative Next Technology has announced a $35 million research and development initiative approved by its board, aimed at strengthening technology reserves and accelerating business expansion. This budget is set for the period ending March 26, 2027. The initiative reflects the company's commitment to enhancing its technological capabilities. https://www.openbell.ai/news/CBOE:1790856553610 2026-10-01T12:09:13.610Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/CBOE.jpg?width=250&height=187 Meta, Millrose Properties, Cboe Global Markets And More On CNBC’s ‘Final Trades’ Cboe Global Markets Inc (NASDAQ:CBOE) is set to announce its third-quarter financial results on October 30. Millrose Properties Inc (NYSE:MRP) declared a quarterly cash dividend of approximately 79 cents per share, resulting in a 12.2% dividend yield. Meta Platforms Inc (NASDAQ:META) is preparing to enter Europe's bond market for the first time, while its shares fell 1.8% to $725.18, and Cboe's shares rose 5.2% to close higher on Wednesday. https://www.openbell.ai/news/MU:1790856532961 2026-10-01T12:08:52.961Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/New-York-City--New-York---August-4-2025-.jpg?width=250&height=187 Micron 'is a Beast': Ross Gerber Declares the Memory Chip Cycle Dead After Monster Earnings, Says 'I've Never Seen Anything Like This' Micron Technology Inc. reported a record fourth-quarter revenue of $54.23 billion, exceeding analyst estimates of $50.75 billion, and adjusted earnings of $33.42 per share. Investor Ross Gerber praised the results, suggesting that Micron has broken away from the traditional boom-and-bust cycle of the memory chip market, which he believes is undergoing a permanent structural shift due to the AI boom. The company's CFO projected first-quarter revenue to be between $60 billion and $63 billion, indicating continued profitability growth. Year-to-date, Micron's stock has risen 273.19%. https://www.openbell.ai/news/EVMN:1790856500429 2026-10-01T12:08:20.429Z daily 0.9 https://cdn.brandfetch.io/EVMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evommune Presents Additional Data From Phase 2a Proof-Of-Concept Trial Of EVO301 In Adults With Atopic Dermatitis At EADV 2026 Congress; Plan To Initiate Subcutaneous Phase 2b Dose-Ranging Trial In Mid-2027 Evommune, Inc. presented additional data from its Phase 2a trial of EVO301 for atopic dermatitis at the EADV 2026 Congress, highlighting its therapeutic signal and favorable safety profile. The trial involved 70 patients and demonstrated comparable efficacy to existing biologics. The company plans to initiate a subcutaneous Phase 2b dose-ranging trial in mid-2027 to further evaluate EVO301's potential. https://www.openbell.ai/news/KD:1790856473962 2026-10-01T12:07:53.962Z daily 0.9 https://cdn.brandfetch.io/KD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kyndryl Opens Its First U.S. AI Innovation Lab In Dallas-Fort Worth Kyndryl (NYSE: KD) has opened its first U.S. AI Innovation Lab in the Dallas-Fort Worth area, which is projected to create up to 300 skilled jobs in AI, technology consulting, and design engineering over the next four years. This initiative underscores Kyndryl's commitment to enhancing America's digital future and fostering innovation and workforce development. https://www.openbell.ai/news/PUSA:1790856468270 2026-10-01T12:07:48.270Z daily 0.9 https://cdn.brandfetch.io/PUSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Powerus Announces Completion Of Merger With Aureus Greenway Holdings, Which Is Renamed Powerus Corporation And Keeps PUSA Ticker openbell Financial News https://www.openbell.ai/news/VEEA:1790856415702 2026-10-01T12:06:55.702Z daily 0.9 https://cdn.brandfetch.io/VEEA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Veea Announces Agreement With TROLLEE Holdings For Phased Deployment Of VeeaONE Solutions Across 1,000 Unattended Stores openbell Financial News https://www.openbell.ai/news/ELAB:1790856353978 2026-10-01T12:05:53.978Z daily 0.9 https://cdn.brandfetch.io/ELAB/w/400/h/400?c=1idopYfmtR7ZKg8QMud PMGC Holdings Says It Is Sponsor Of $100M SPAC NorthStrive Acquisition Corp I, Holding About 21.4% Stake openbell Financial News https://www.openbell.ai/news/DOMH:1790856351639 2026-10-01T12:05:51.639Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Financials Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, Dominari Holdings (NASDAQ: DOMH) saw a 7.3% increase in share price, reaching $2.35, with a market value of $53.0 million. Other notable gainers included Top KingWin Ltd (DPU) up 6.57% to $1.62 and Nu Holdings (NU) rising 5.76% to $13.39, with a market cap of $60.8 billion. Conversely, Lion Group Holding (LGHL) experienced the largest drop, falling 20.8% to $4.5, while Grande Group (GRAN) decreased by 17.19% to $0.9. https://www.openbell.ai/news/MEDS:1790856351396 2026-10-01T12:05:51.396Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, DataMEDS AI (NASDAQ: MEDS) saw a significant increase of 39.4%, reaching $4.42, with a market cap of $10.1 million. Other notable gainers included Stablecoin Development (AMEX: SDEV) up 30.1% to $3.37 and Filana Therapeutics (NASDAQ: FLNA) rising 15.14% to $1.02. Conversely, Foghorn Therapeutics (NASDAQ: FHTX) experienced a sharp decline of 47.9%, dropping to $1.86, while NewGenIvf Group (NASDAQ: NIVF) fell 27.68% to $0.12. https://www.openbell.ai/news/RAIN:1790856351147 2026-10-01T12:05:51.147Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, Rain Enhancement (NASDAQ: RAIN) saw its stock rise 18.7% to $0.95, with a market value of $9.3 million. Quanome Technologies (NASDAQ: QNME) also gained 16.48%, reaching $0.62, and has a market value of $18.3 million following its recent Q4 earnings release. On the downside, LiqTech International (NASDAQ: LIQT) shares fell 17.0% to $0.44, with a market cap of $17.4 million. https://www.openbell.ai/news/VEEA:1790856350922 2026-10-01T12:05:50.922Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's Pre-Market Session In Thursday's pre-market session, Veea (NASDAQ: VEEA) shares surged by 41.0% to $3.06, with a market value of $6.7 million. Socket Mobile (NASDAQ: SCKT) also saw a significant increase of 34.69% to $0.6, while Accenture (NYSE: ACN) rose by 17.24% to $215.0 following its Q4 earnings report. On the downside, Veritone (NASDAQ: VERI) experienced a sharp decline of 19.3% to $0.96, with a market cap of $119.5 million. https://www.openbell.ai/news/SNPS:1790856330788 2026-10-01T12:05:30.788Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Synopsys--Inc.jpg?width=250&height=187 What's Going On With Synopsys Shares Thursday? Synopsys Inc. (NASDAQ: SNPS) shares rose 3.46% to $450.00 following the company's fiscal-year 2027 financial guidance, which includes GAAP earnings projected between $8.16 and $8.61 per share and revenue expectations of $11.1 billion to $11.2 billion, both exceeding consensus estimates. Additionally, Synopsys plans a $1 billion share buyback and announced partnerships with OpenAI and Amazon, including a multi-year agreement worth over $1 billion with Amazon to enhance custom chip engineering. The company aims for mid-teens annual revenue growth and a fiscal 2030 operating margin of around 50%. https://www.openbell.ai/news/CTVA:1790856293531 2026-10-01T12:04:53.531Z daily 0.9 https://cdn.brandfetch.io/CTVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Corteva Completes Spin Off Of Its Advanced Seed And Genetics Business Corteva, Inc. (NYSE: CTVA) has successfully completed the spin-off of its advanced seed and genetics business. Following this strategic move, Corteva will operate as a focused global crop protection company. https://www.openbell.ai/news/XHLD:1790856255488 2026-10-01T12:04:15.488Z daily 0.9 https://cdn.brandfetch.io/XHLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud TEN Holdings Rolls Out Digital Experience Platform TEN TEN Holdings, Inc. (Nasdaq: XHLD) has launched TEN, a new Digital Experience Platform that serves as the technological foundation for the company's long-term growth strategy. This initiative is part of TEN Holdings' efforts to enhance its digital capabilities and drive future growth. https://www.openbell.ai/news/AKTS:1790856253887 2026-10-01T12:04:13.887Z daily 0.9 https://cdn.brandfetch.io/AKTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519 Aktis Oncology has initiated a second Phase 1b clinical trial, named BActinium-2, to evaluate its drug AKY-2519 in patients with non-small cell lung cancer (NSCLC) and other tumors expressing B7-H3. The company is also currently enrolling patients in the Phase 1b BActinium-1 trial for AKY-2519 targeting metastatic castration-resistant prostate cancer (mCRPC), with preliminary data anticipated in 2027. https://www.openbell.ai/news/SNPS:1790856251761 2026-10-01T12:04:11.761Z daily 0.9 https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rosenblatt Maintains Buy on Synopsys, Raises Price Target to $620 Rosenblatt analyst Blair Abernethy has maintained a Buy rating on Synopsys (NASDAQ: SNPS) and increased the price target from $575 to $620. This adjustment reflects a positive outlook on the company's performance in the market. https://www.openbell.ai/news/VYLR:1790856222701 2026-10-01T12:03:42.701Z daily 0.9 https://cdn.brandfetch.io/VYLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vylor Completes Its Separation From Corteva, To Trade On Nasdaq Under VYLR Symbol Vylor has successfully completed its separation from Corteva Inc. and will commence trading as an independent company on the New York Stock Exchange under the ticker symbol 'VYLR' starting October 1, 2026. https://www.openbell.ai/news/BWXT:1790856202089 2026-10-01T12:03:22.089Z daily 0.9 https://cdn.brandfetch.io/BWXT/w/400/h/400?c=1idopYfmtR7ZKg8QMud BWX Technologies Announces $189M Contract To Manufacture Nuclear Fuel For U.S. Navy Through August 2027 openbell Financial News https://www.openbell.ai/news/MU:1790856186880 2026-10-01T12:03:06.880Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rosenblatt Maintains Buy on Micron Technology, Raises Price Target to $1900 Rosenblatt analyst Kevin Cassidy has maintained a Buy rating on Micron Technology (NASDAQ: MU) and increased the price target from $1500 to $1900. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/NNE:1790856170475 2026-10-01T12:02:50.475Z daily 0.9 https://cdn.brandfetch.io/NNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud NANO Nuclear Energy, HALEU Energy Fuel Subsidiary Ink Agreement With Radnostix To Acquire U.S. Nuclear Fuel Processing Assets For $9M In Cash, $5M In NANO Common Shares NANO Nuclear Energy Inc. (NASDAQ: NNE) and its subsidiary, HALEU Energy Fuel Inc., have signed an agreement to acquire U.S. nuclear fuel processing assets from Radnostix, Inc. for a total of $9.5 million in cash and $4 million in NANO common stock. The assets include a U.S. Nuclear Regulatory Commission license and related intellectual property for a depleted uranium hexafluoride deconversion facility in New Mexico. The transaction is expected to close in 90 to 120 days, pending necessary regulatory approvals. https://www.openbell.ai/news/PRGS:1790856070950 2026-10-01T12:01:10.950Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Section-Of-A-Financial-Newspaper-Titled-.jpg?width=250&height=187 Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session Progress Software Corp (NASDAQ: PRGS) reported third-quarter revenue of $246 million, a 2% decline year over year, while non-GAAP EPS increased by 13% to $1.69, and ARR rose 1% to $873 million. In pre-market trading, shares of Progress Software fell 2.3% to $39.05 following the earnings report. Overall, U.S. stock futures were mixed, with the Dow futures down approximately 200 points. https://www.openbell.ai/news/CVEO:1790855965217 2026-10-01T11:59:25.217Z daily 0.9 https://cdn.brandfetch.io/CVEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Initiates Coverage On Civeo with Buy Rating, Announces Price Target of $39 Roth Capital analyst Tom Hayes has initiated coverage on Civeo (NYSE: CVEO) with a Buy rating. The firm has set a price target of $39 for the company's stock. https://www.openbell.ai/news/MI:1790855863269 2026-10-01T11:57:43.269Z daily 0.9 https://cdn.brandfetch.io/MI/w/400/h/400?c=1idopYfmtR7ZKg8QMud NFT shares are trading lower after the company announced a $36 million offering of 80 million shares at $0.45 per share. openbell Financial News https://www.openbell.ai/news/ABAT:1790855659014 2026-10-01T11:54:19.014Z daily 0.9 https://cdn.brandfetch.io/ABAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud American Battery Technology shares are trading higher after the company announced it received approval from the U.S. Department of Commerce's Bureau of Industry and Security's for the sale of up to $100 million of its recycled black mass material. openbell Financial News https://www.openbell.ai/news/RZAI:1790855525380 2026-10-01T11:52:05.380Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Stock-Graph-With-Green-Candle-Spike.jpg?width=250&height=187 Why Is Roze AI Stock Surging Thursday? Roze AI Inc. (NASDAQ: RZAI) saw its stock surge over 90% in premarket trading on Thursday, reaching $42.00, just two days after its Nasdaq debut on September 29. The company, which specializes in AI technology for fire risk identification, completed its listing through a direct listing rather than a traditional IPO. Roze AI aims to support its international expansion with this listing, primarily generating revenue from fire detection products in South Korea. https://www.openbell.ai/news/PBK:1790855333805 2026-10-01T11:48:53.805Z daily 0.9 https://cdn.brandfetch.io/PBK/w/400/h/400?c=1idopYfmtR7ZKg8QMud PowerBank Receives Nasdaq Notification Granting An Additional 180-Day Compliance Period Until March 28, 2027 openbell Financial News https://www.openbell.ai/news/ABAT:1790855306067 2026-10-01T11:48:26.067Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Abstract-Images--Candlestick-Charts-For-.jpg?width=250&height=187 American Battery Technology Stock Surges Thursday: What's Happening? American Battery Technology Co (NASDAQ: ABAT) shares surged 17.19% to $2.59 during premarket trading on Thursday after the company received federal regulatory approval to export up to $100 million of recycled battery material. The approval from the Department of Commerce allows the sale of black mass, which contains critical minerals such as lithium and cobalt, enhancing the company's access to international supply chains. CEO Ryan Melsert highlighted the support from the U.S. government and the company's ongoing expansion efforts, including a second recycling facility backed by $150 million in grants from the Department of Energy. https://www.openbell.ai/news/MKC:1790855055196 2026-10-01T11:44:15.196Z daily 0.9 https://cdn.brandfetch.io/MKC/w/400/h/400?c=1idopYfmtR7ZKg8QMud McCormick shares are trading higher after the company reported better-than-expected Q3 financial results openbell Financial News https://www.openbell.ai/news/IBM:1790855053403 2026-10-01T11:44:13.403Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Dusseldorf--North-Rhine-westphalia--Germ.jpg?width=250&height=187 IBM Stock Rises After Unveiling Self-Hosted Deployment for IBM Bob IBM shares rose 5.94% to $233.00 following the announcement of a self-hosted deployment option for its AI software development platform, IBM Bob. This new feature allows enterprises, particularly in regulated industries, to manage AI-powered software development within their own environments, enhancing data security and governance. The deployment option is designed to support on-premises, private-cloud, and air-gapped environments, addressing the need for greater control over sensitive data and compliance. https://www.openbell.ai/news/CVEO:1790855043992 2026-10-01T11:44:03.992Z daily 0.9 https://cdn.brandfetch.io/CVEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Northland Capital Markets Initiates Coverage On Civeo with Outperform Rating, Announces Price Target of $42 Northland Capital Markets has initiated coverage on Civeo (NYSE: CVEO) with an Outperform rating and set a price target of $42. This marks a positive outlook for the company as analysts begin to assess its market potential. https://www.openbell.ai/news/NVR:1790854945943 2026-10-01T11:42:25.943Z daily 0.9 https://cdn.brandfetch.io/NVR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Initiates Coverage On NVR with Underweight Rating, Announces Price Target of $5058 Morgan Stanley has initiated coverage on NVR (NYSE: NVR) with an Underweight rating, setting a price target of $5,058. Analyst Adam Kramer is leading this assessment, indicating a cautious outlook for the company. https://www.openbell.ai/news/ORCL:1790854896581 2026-10-01T11:41:36.581Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Austin--Tx--Usa---Apr-11--2025-Oracle-Si.jpg?width=250&height=187 Oracle Lands $7 Billion Tencent AI Deal — Chinese Tech Giant to Access 100,000 Advanced Chips Through Southeast Asia Data Centers: Report Oracle Corporation has entered a $7 billion lease agreement with Tencent Holdings Ltd. for access to 100,000 advanced AI chips through its data centers in Southeast Asia. The deal, which spans five years, requires approximately 30% of the payment upfront and aims to enhance Tencent's AI capabilities. Following the announcement, Oracle's shares rose 1.86% to $139.85 in pre-market trading, although the company's stock has declined 29.56% year-to-date. https://www.openbell.ai/news/VICR:1790854870116 2026-10-01T11:41:10.116Z daily 0.9 https://cdn.brandfetch.io/VICR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vicor shares are trading higher after the company raised its Q3 sequential revenue growth guidance. Also, the company issued Q3 revenue guidance above estimates. openbell Financial News https://www.openbell.ai/news/TOL:1790854656758 2026-10-01T11:37:36.758Z daily 0.9 https://cdn.brandfetch.io/TOL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Initiates Coverage On Toll Brothers with Overweight Rating, Announces Price Target of $159 Morgan Stanley analyst Adam Kramer has initiated coverage on Toll Brothers (NYSE: TOL) with an Overweight rating. The firm has set a price target of $159 for the company's stock. https://www.openbell.ai/news/CEG:1790854626765 2026-10-01T11:37:06.765Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Constellation Energy shares are trading higher after the company announced a long-term agreement that will support the continued investment in and expansion of the Calvert Cliffs Clean Energy Center. openbell Financial News https://www.openbell.ai/news/SPY:1790854608607 2026-10-01T11:36:48.607Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fed's Kashkari Says Economy Keeps Surprising Me How Resilient It Is Neel Kashkari, president of the Federal Reserve Bank of Minneapolis, expressed surprise at the resilience of the U.S. economy during a recent Bloomberg TV interview. He noted that the economy continues to perform better than expected, indicating potential implications for monetary policy. No specific financial figures or market impacts were mentioned in the article. https://www.openbell.ai/news/SNPS:1790854554606 2026-10-01T11:35:54.606Z daily 0.9 https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Synopsys shares are trading higher after the company issued FY27 guidance above estimates. openbell Financial News https://www.openbell.ai/news/BA:1790854543525 2026-10-01T11:35:43.525Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Boeing-airplane.jpg?width=250&height=187 What's Going On With Boeing Stock Thursday? Boeing has secured multiple new contracts, including a multi-billion-dollar agreement with the U.S. Navy for its F/A-XX sixth-generation fighter program, aimed at replacing the F/A-18 Super Hornet fleet. Additionally, Ethiopian Airlines ordered eight Boeing 777-8 Freighters, marking a significant expansion of its cargo fleet. Boeing is set to report its third-quarter results on October 27, with analysts expecting a revenue increase to $24.99 billion and a loss of 9 cents per share. As of Thursday, Boeing shares were trading at $186.60, up 0.30% in premarket activity. https://www.openbell.ai/news/HMC:1790854508350 2026-10-01T11:35:08.350Z daily 0.9 https://cdn.brandfetch.io/HMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Honda Motors Engages With Redwire To Develop Robotics Solution For Future Commercial Space Stations To Reduce Time Needed For Astronauts To Conduct Experiments And Laboratory Operations In Space Honda Motors is collaborating with Redwire to develop a robotics solution aimed at enhancing research capabilities aboard future commercial space stations. The initiative will integrate Honda's multi-fingered robotic hand with Redwire's STAARK robotic arm to automate experiment handling and laboratory tasks, thereby reducing the time astronauts spend on these operations. Both companies plan to engage with commercial station developers and potential partners at the 2026 International Astronautical Congress. https://www.openbell.ai/news/PEP:1790854483426 2026-10-01T11:34:43.426Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/01/Hershey.jpg?width=250&height=187 Top 3 Risk Off Stocks You'll Regret Missing This Month The article highlights three oversold stocks in the consumer staples sector: PepsiCo Inc (NASDAQ: PEP), Mondelez International Inc (NASDAQ: MDLZ), and Hershey Co (NYSE: HSY). PepsiCo's stock has an RSI of 25.4 and closed at $126.72, with a recent price target reduction from $150 to $135. Mondelez has an RSI of 27.4, closing at $57.82, while Hershey's RSI is at 22.1, with shares closing at $157.61 after a recent leadership change. https://www.openbell.ai/news/ACN:1790854378692 2026-10-01T11:32:58.692Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Accenture shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY27 sales guidance above estimates. openbell Financial News